As nouns the difference between protein and eculizumab

is that protein is protein while eculizumab is a monoclonal antibody directed against the complement protein c5.

As nouns the difference between infection and efungumab

is that infection is (pathology) the act or process of infecting while efungumab is a human monoclonal antibody intended to treat invasive candida infection in combination with amphotericin b.

As nouns the difference between amphotericin and efungumab

is that amphotericin is any of a group of amphoteric antibiotic and antifungal agents derived from Streptomyces bacteria while efungumab is a human monoclonal antibody intended to treat invasive Candida infection in combination with amphotericin B.

As nouns the difference between mouse and elsilimomab

is that mouse is any small rodent of the genus mus while elsilimomab is a mouse monoclonal antibody used as an immunosuppressive drug.

As a verb mouse

is to move cautiously or furtively, in the manner of a mouse (the rodent) (frequently used in the phrasal verb to mouse around ).

As nouns the difference between immunosuppressive and elsilimomab

is that immunosuppressive is (pharmacology) an agent which is capable of immunosuppression while elsilimomab is a mouse monoclonal antibody used as an immunosuppressive drug.

As an adjective immunosuppressive

is (pharmacology) having the capability to suppress the immune system, capable of immunosuppression.

As nouns the difference between drug and elsilimomab

is that drug is (pharmacology) a substance used to treat an illness, relieve a symptom, or modify a chemical process in the body for a specific purpose or drug can be (obsolete) a drudge while elsilimomab is a mouse monoclonal antibody used as an immunosuppressive drug.

As a verb drug

is to administer intoxicating drugs to, generally without the recipient's knowledge or consent or drug can be (drag).

As nouns the difference between malignant and ecromeximab

is that malignant is while ecromeximab is a chimeric monoclonal antibody being developed for the treatment of malignant melanoma.

As an adjective malignant

is harmful, malevolent, injurious.

As nouns the difference between melanoma and ecromeximab

is that melanoma is a dark-pigmented, usually malignant tumor arising from a melanocyte and occurring most commonly in the skin while ecromeximab is a chimeric monoclonal antibody being developed for the treatment of malignant melanoma.

As an adjective human

is (label) classical (of or pertaining to the classical - latin, greek - languages, literature, history and philosophy).

As a noun efungumab is

a human monoclonal antibody intended to treat invasive candida infection in combination with amphotericin b.

As nouns the difference between invasive and efungumab

is that invasive is an invasive organism, as, a plant or animal while efungumab is a human monoclonal antibody intended to treat invasive candida infection in combination with amphotericin b.

As an adjective invasive

is that invades a foreign country using military force.